China Shineway Pharmaceutical Group Ltd

Common Name
Shineway Pharmaceutical Group
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3,220
Ticker
2877
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
China Shineway Pharmaceutical Group Limited is a leading Chinese pharmaceutical company specializing in the development, manufacturing, and marketing of a variety of traditional Chinese medicine (TCM)...

Shineway Pharmaceutical Group's Climate Target Data Preview

As of 2024, Shineway Pharmaceutical Group has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 intensity-based target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Shineway Pharmaceutical Group ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Intensity-based Target
Scope 1 - Total, Scope 2 - Total, Scope 3 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue
Copy restricted. Please purchase to unlock this data.
a
2025
Download Shineway Pharmaceutical Group's Climate Targets data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind Shineway Pharmaceutical Group’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Shineway Pharmaceutical Group’s data sources below and access millions more through our Disclosure Search.

a. Shineway Pharmaceutical Group's ESG Report 2024
Trace every data point back to Shineway Pharmaceutical Group’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into Shineway Pharmaceutical Group's Greenhouse Gas Emissions Pathways

As of 2024, Shineway Pharmaceutical Group has set greenhouse gas (GHG) emissions reduction targets that cover only its total carbon footprint, without separate targets for operational (Scope 1 and 2) or value chain (Scope 3) emissions. This limits the ability to track progress across distinct emissions categories. a

Want Full Access to Shineway Pharmaceutical Group's Climate Targets Dataset?
Sign Up